Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1,147,663,152
-
Total 13F shares
-
519,485,533
-
Share change
-
+11,620,996
-
Total reported value
-
$29,335,153,511
-
Put/Call ratio
-
96%
-
Price per share
-
$56.46
-
Number of holders
-
805
-
Value change
-
+$628,822,684
-
Number of buys
-
302
-
Number of sells
-
407
Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q3 2015
As of 30 Sep 2015,
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) was held by
805 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
519,485,533 shares.
The largest 10 holders included
FMR LLC, FRANKLIN RESOURCES INC, Invesco Ltd., PAULSON & CO. INC., WADDELL & REED FINANCIAL INC, LAZARD ASSET MANAGEMENT LLC, BARROW HANLEY MEWHINNEY & STRAUSS LLC, NORGES BANK, Viking Global Investors LP, and BANK OF AMERICA CORP /DE/.
This page lists
806
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.